Carefusion Corp (CFN) 59.91 $CFN
Stryker announces completion of the acquisition of vertebral compression fracture portfolio from BD
Globe Newswire - Thu Apr 21, 7:00AM CDT
Kalamazoo, Michigan - April 21, 2016 - Stryker Corporation (NYSE: SYK) announced today it has completed the acquisition of the CareFusion vertebral compression fracture (VCF) portfolio of products from BD (Becton, Dickinson and Company) in an all cash transaction. The portfolio is comprised of minimally-invasive systems used in vertebroplasty and vertebral augmentation procedures. BD acquired these assets as a part of CareFusion's portfolio in March of 2015.
CFN: 59.91 (-0.06), SYK: 114.56 (-0.77)
Global Infusion Pumps Market Worth USD 4922 Million by 2025 - Analysis, Technologies & Forecasts Report 2015-2025 - Key Vendors: Baxter, Braun, CareFusion - Research and Markets
BusinessWire - Mon Apr 11, 4:03AM CDT
Research and Markets has announced the addition of the "Infusion Pumps Market: Global Industry Analysis and Opportunity Assessment, 2015-2025" report to their offering.
CFN: 59.91 (-0.06)
United States Breast Biopsy and Imaging Market 2016
M2 - Fri Jan 15, 3:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/lxb4c5/us_market_for) has announced the addition of the "US Market for Breast Biopsy and Imaging - 2016" report to their offering. In recent years, improvements in breast imaging technology, especially in breast ultrasound technology, have enhanced a physician's ability to identify more and smaller microcalcifications in the breast. The breast imaging market includes analog, computed and digital radiography mammography, digital breast tomosynthesis, manual and automated breast ultrasound, gamma imaging, positron emission mammography and breast MRI coils. Improvements in breast imaging techniques are expected to help increase the number of breast biopsy procedures and therefore, sales of breast biopsy devices, as more breast lesions are detected. New mammography technologies and the growth of complementary modalities have grown the breast imaging market. Key Topics Covered: 1 Overview 1.1 Breast Biopsy Device Market 1.2 Breast Imaging Equipment Market 2 Research Methodology 3 Breast Biopsy Device Market 3.1 Introduction 3.2 Market Overview 3.3 Market Analysis And Forecast 3.3.1 Total Breast Biopsy Device Market 3.3.2 Core Needle Device Market 3.3.3 Total Vacuum-Assisted Breast Biopsy Device Market 3.3.3.1 Vacuum-Assisted Breast Biopsy Device Market By Imaging Modality 3.3.3.1.1 Ultrasound Guided Vabb Market 3.3.3.1.2 Stereotactic X-Ray Guided Vabb Market 3.3.3.1.3 Mri Guided Vabb Market 3.3.3.1.4 Molecular Imaging Guided Vabb Market 3.4 Market Drivers And Limiters 3.4.1 Market Drivers 3.4.2 Market Limiters 3.5 Competitive Analysis 4 Breast Imaging Equipment Market 4.1 Introduction 4.1.1 Mammography 4.1.1.1 Analog Mammography 4.1.1.2 Computed Radiography (Cr) 4.1.1.3 Digital Radiography (Dr) 4.1.1.4 Digital Breast Tomosynthesis (Dbt) 4.1.2 Ultrasound Imaging 4.1.2.1 Manual Breast Ultrasound 4.1.2.2 Automated Breast Ultrasound System (Abus) 4.1.3 Breast Magnetic Resonance Imaging 4.1.4 Molecular Breast Imaging (Mbi) 4.1.4.1 Gamma Imaging 4.1.4.2 Positron Emission Mammography (Pem) 4.2 Market Overview 4.3 Market Analysis And Forecast 4.3.1 Total Mammography Market 4.3.1.1 Analog Mammography Market 4.3.1.2 Computed Radiography Mammography Market 4.3.1.3 Digital Radiography Mammography Market 4.3.1.4 Digital Breast Tomosynthesis Market 4.3.2 Molecular Breast Imaging Market 4.3.2.3 Positron Emission Mammography Market 4.3.2.2 Gamma Imaging Market 4.3.3 Total Breast Ultrasound Market 4.3.3.1 Manual Breast Ultrasound Market 4.3.3.2 Automated Breast Ultrasound System Market 4.3.4 Mri Coil Market 4.4 Drivers And Limiters 4.5 Competitive Analysis Companies Mentioned - Hologic - Mammotome (Devicor) - C. R. Bard - CareFusion - Intact Medical - Scion Medical Technologies - GE Healthcare - Philips Medical Systems - Siemens Healthcare - Fujifilm - Toshiba - SuperSonic Imagine - SonoCin? - CMR-Naviscan - Hitachi - Gamma Medica Inc. - Dilon Technologies - Machnet B.V. - Planmed OY For more information visit http://www.researchandmarkets.com/research/lx...market_for
CFN: 59.91 (-0.06), HOLX: 34.14 (-0.81)
US Female & Neonatal Diagnostic Device Market Report - Analysis, Technologies & Forecasts 2016
M2 - Mon Jan 11, 6:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/cnfsfw/us_female_and) has announced the addition of the "US Female and Neonatal Diagnostic Device Market Report Suite - 2016" report to their offering. This report includes analysis and forecasting for the markets for bone densitometry (central and peripheral), breast biopsy devices (spring-loaded core needles, VABB devices, as well as breakdowns for stereotactic X-ray, ultrasound and MRI guidance), breast imaging (mammography, breast ultrasound, breast MRI coils, gamma imaging and positron emission mammography), OB/GYN ultrasound imaging, fetal and neonatal monitoring (hospital, alternate and home-use), as well as incubators and warmers. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, fetal and neonatal monitoring, infant warmers and incubators. The majority of these market segments will see stable growth throughout the forecast period of this report. In 2015, the largest segment of this market was represented by breast imaging. Companies Mentioned: - Hologic - GE Healthcare - Philips Healthcare - Siemens Healthcare - Mammotome (Devicor) - C.R. Bard - Samsung Medison - Dr?ger Medical - Norland, at Swissray - Laborie - AGFA Healthcare - Assured Imaging Mobile Mammography - Atmos Medical BeamMed - Biosound Esaote - BK Medical - CareFusion - Carestream Health - CAS Medical - CMR-Naviscan - Dilon Technologies - Dr?ger Medical - Fischer-Giotto - Fujifilm Medical - Fujifilm Sonosite - Fukuda Denshi - Gamma Medica Inc. - Hitachi Aloka Medical America Inc. - Huntleigh Healthcare - Intact Medical - International Biomedical - Konica Minolta - Laborie - Loan Oak Medical Technologies - Machnet - Mindray - Natus Medical - Nihon Kohden - Osteometer Meditech - Planmed OY - Samsung Medison - Scion Medical Technologies - SonoCine - Spacelabs Healthcare - SuperSonic Imagine - Toshiba America Medical Systems - Zonare Medical Systems Report Structure: 1. U.S. FEMALE AND NEONATAL DIAGNOSTIC DEVICE MARKET 2. RESEARCH METHODOLOGY 3. U.S. FEMALE AND NEONATAL DIAGNOSTIC DEVICE MARKET OVERVIEW 4. PROCEDURE NUMBERS 5. BONE DENSITOMETRY MARKET 6. BREAST BIOPSY DEVICE MARKET 7. BREAST IMAGING EQUIPMENT MARKET 8. OBSTETRICS AND GYNECOLOGY ULTRASOUND EQUIPMENT MARKET 9. FETAL AND NEONATAL MONITORING DEVICE MARKET 10. INFANT WARMER AND INCUBATOR MARKET 11. GYNECOLOGICAL CHAIR MARKET 12. ABBREVIATIONS 13. PROCEDURAL CODES For more information visit http://www.researchandmarkets.com/research/cn...female_and
BABY: 36.39 (-0.32), CFN: 59.91 (-0.06), MDSY: 1.50 (-0.04), HOLX: 34.14 (-0.81)
US Female and Neonatal Devices Procedure Numbers Report - Analysis, Technologies & Forecasts 2016
M2 - Mon Jan 11, 6:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/kg78mz/us_procedure) has announced the addition of the "US Procedure Numbers for Female and Neonatal Devices Featuring DXA, Breast Biopsy, Breast Imaging, and OB/GYN Ultrasound Procedures - 2016" report to their offering. This report includes analysis and forecasting for the markets for bone densitometry (central and peripheral), breast biopsy devices (spring-loaded core needles, VABB devices, as well as breakdowns for stereotactic X-ray, ultrasound and MRI guidance), breast imaging (mammography, breast ultrasound, breast MRI coils, gamma imaging and positron emission mammography), OB/GYN ultrasound imaging, fetal and neonatal monitoring (hospital, alternate and home-use), as well as incubators and warmers. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, fetal and neonatal monitoring, infant warmers and incubators. The majority of these market segments will see stable growth throughout the forecast period of this report. In 2015, the largest segment of this market was represented by breast imaging. This is primarily due to the large number of screening procedures performed with these devices, which add to the demand of the devices as well as the introduction of new technologies such as digital breast tomosynthesis (DBT) and automated breast ultrasound (ABUS). Moreover, the ASP of these devices is high in comparison to the devices from other markets discussed in this report. Companies Mentioned: - Hologic - GE Healthcare - Philips Healthcare - Siemens Healthcare - Mammotome (Devicor) - C.R. Bard - Samsung Medison - Dr?ger Medical - Norland, at Swissray - Laborie - AGFA Healthcare - Assured Imaging Mobile Mammography - Atmos Medical BeamMed - Biosound Esaote - BK Medical - CareFusion - Carestream Health - CAS Medical - CMR-Naviscan - Dilon Technologies - Dr?ger Medical - Fischer-Giotto - Fujifilm Medical - Fujifilm Sonosite - Fukuda Denshi - Gamma Medica Inc. - Hitachi Aloka Medical America Inc. - Huntleigh Healthcare - Intact Medical - International Biomedical - Konica Minolta - Laborie - Loan Oak Medical Technologies - Machnet - Mindray - Natus Medical - Nihon Kohden - Osteometer Meditech - Planmed OY - Samsung Medison - Scion Medical Technologies - SonoCine - Spacelabs Healthcare - SuperSonic Imagine - Toshiba America Medical Systems - Zonare Medical Systems Report Structure: 1.1 PROCEDURE NUMBERS 2. RESEARCH METHODOLOGY 3. PROCEDURE NUMBERS 4. ABBREVIATIONS 5. PROCEDURAL CODES For more information visit http://www.researchandmarkets.com/research/kg..._procedure
BABY: 36.39 (-0.32), CFN: 59.91 (-0.06), MDSY: 1.50 (-0.04), HOLX: 34.14 (-0.81)
mHealth and Home Monitoring Market Report: 2015 Edition - How Should the Mobile Industry Address the Vast Business Opportunity in Wireless Healthcare Monitoring
M2 - Wed Dec 16, 3:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/jnfv9z/mhealth_and_home) has announced the addition of the "mHealth and Home Monitoring - 7th Edition " report to their offering. How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? The number of home monitoring devices on the global market with integrated cellular connectivity was 3.0 million at the end of 2015 and is forecasted to grow at a CAGR of 45.4 percent in the next five years to reach 19.2 million in 2020. Learn more about how wireless technology can become seamlessly integrated with medical devices in this 250 page in-depth report now in its seventh edition. mHealth and Home Monitoring is the seventh consecutive report that gives first-hand insights into the adoption of wireless solutions for health monitoring. This strategic research report provides you with 250 pages of unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions. This report will allow you to: - Profit from 40 new executive interviews with market leading companies. - Study the strategies of 108 key players in the mHealth ecosystem. - Learn about key home health monitoring devices and services. - Understand the dynamics of the health monitoring market in Europe and North America. - Comprehend how wireless technology can become seamlessly integrated with medical devices. - Evaluate the business opportunities in the emerging mHealth segment. - Predict future market and technology developments. This report answers the following questions: - Which medical conditions offer the best potential for wireless health monitoring solutions? - Who are the leading providers of connected medical devices? - What are the mHealth strategies of medical device vendors and pharmaceutical companies? - Which are the general technology trends for home health monitoring equipment? - What initiatives have been taken by the leading players in the telecom and IT industries? - How can connectivity redefine the use cases of medical devices and the value propositions to patients and other stakeholders? - What are the market shares of the top 5 integrated telehealth solution vendors? - Why are smartphone applications so significant for the mHealth market? - How can healthcare providers and payers benefit from mHealth solutions? Key Topics Covered: Executive summary 1 The challenge from welfare diseases 2 mHealth platforms 3 Physiological monitoring solution providers 4 Medication and integrated monitoring solution providers 5 Market analysis and forecasts Companies Mentioned - 35 of the 100 Companies Featured - A&D Medical - AT&T - Abbott - Aerocrine - Aerotel Medical Systems - Alere - AliveCor - Apple HealthKit - AstraZeneca - AuthentiDate - Bayer Healthcare - BePatient - BioTelemetry - Biotronik - BodyTel - Bosch Healthcare - Boston Scientific - Cadwell Laboratories - CardioComm Solutions - Cardiocom - Care Innovations - CareFusion - ChoiceMMed - Clement Clarke International - CoaguSense - Compliance Meds Technologies - Compumedics - DayaMed - Dexcom - Domicalis - eDevice - Ericsson - Evondos - Exco InTouch - Fisher & Paykel Healthcare For more information visit http://www.researchandmarkets.com/research/jn...h_and_home
BSX: 23.02 (-0.30), CFN: 59.91 (-0.06), MDSY: 1.50 (-0.04)
CareFusion Receives Two 510(K) Clearances for Spine Products
M2 - Fri Dec 11, 8:19AM CST
CareFusion, a BD company (NYSE:BDX), today announced the U.S. Food and Drug Administration (FDA) has cleared two 510(k)s for its spine augmentation devices.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06)
Global Respiratory Disease Testing Market 2015-2019 - Key Vendors are Alere, CareFusion, Nihon Kohden, Philips Healthcare & Smiths Medical
PR Newswire Europe - Tue Dec 08, 4:01AM CST
DUBLIN, December 8, 2015 /PRNewswire/ --
CFN: 59.91 (-0.06)
BD Introduces Simplified Comprehensive IV Management
M2 - Mon Dec 07, 10:15AM CST
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a simplified way for hospitals to manage intravenous (IV) medication to help improve safety and reduce waste.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06)
Research and Markets: Metabolic Testing Solutions - Global Strategic Business Report - Key Players are AEI Technologies, Bodystat, CareFusion, CORTEX Biophysik GmbH & COSMED
BusinessWire - Fri Dec 04, 7:21AM CST
Research and Markets (http://www.researchandmarkets.com/research/xwsjvw/metabolic_testing) has announced the addition of the "Metabolic Testing Solutions - Global Strategic Business Report" report to their offering.
CFN: 59.91 (-0.06)
Global Respiratory Disease Testing Market 2015-2019
M2 - Fri Dec 04, 5:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/fb79kb/global) has announced the addition of the "Global Respiratory Disease Testing Market 2015-2019" report to their offering. The report forecasts the global respiratory disease testing market to grow at a CAGR of 7.46% over the period 2014-2019 The report covers the current scenario and the growth prospects of the global respiratory disease testing market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of testing devices used to diagnose acute and chronic respiratory diseases. The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the landscape of the global respiratory disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Market landscape PART 06: Market segmentation by test PART 07: Market segmentation by mechanical and screening test PART 08: Market segmentation by IVD test PART 09: Geographical segmentation PART 10: Market drivers PART 11: Impact of drivers PART 12: Market challenges PART 13: Impact of drivers and challenges PART 14: Market trends PART 15: Vendor landscape PART 16: Key vendor analysis - Alere - CareFusion - COSMED - Nihon Kohden - Philips Healthcare - Smiths Medical - Diamedix - Affymetrix - Seegene - Cepheid - NDD Medical Technologies - COSMED - Abbott - F. Hoffmann-La Roche - Siemens Healthcare - Instrumentation Laboratories - Covidien - SDI Diagnostics - Futuremed America. For more information visit http://www.researchandmarkets.com/research/fb79kb/global
CFN: 59.91 (-0.06), CPHD: 28.27 (-0.60)
Metabolic Testing Solutions - Global Strategic Business Report - Key Players are AEI Technologies, Bodystat, CareFusion, CORTEX Biophysik GmbH & COSMED
M2 - Fri Dec 04, 4:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/klmhsw/metabolic_testing) has announced the addition of the "Metabolic Testing Solutions - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Metabolic Testing Solutions in US$ Thousand by the following Product Segments: ECGs/EKGs, Metabolic Carts, CPET Systems, and Others. The market is also analyzed by the following Technologies: VO2 Max Analysis, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 91 companies including many key and niche players such as - - AEI Technologies, Inc. - Bodystat Limited - CareFusion Corporation - CORTEX Biophysik GmbH - COSMED Key Topics Covered: 1. OUTLOOK 2. INDUSTRY OVERVIEW 3. PRODUCT OVERVIEW 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS - AEI Technologies, Inc. (US) - Bodystat Limited (UK) - CareFusion Corporation (US) - CORTEX Biophysik GmbH (Germany) - COSMED (Italy) - GE Healthcare (UK) - Geratherm Medical AG (Germany) - Hologic, Inc. (US) - InBody Co., Ltd. (South Korea) - Iworx Systems, Inc. (US) - Jawon Medical Co. Ltd. (South Korea) - KORR Medical Technologies, Inc. (US) - Laica SpA (Italy) - MGC Diagnostics Corporation (US) - Microlife Medical Home Solutions, Inc. (US) - Mindray Medical International Limited (China) - Mortara Instrument, Inc. (US) - Nihon Kohden Corporation (Japan) - Noraxon U.S.A., Inc. (US) - Omron Healthcare, Inc. (US) - Parvo Medics (US) - Philips Healthcare (Netherlands) - RJL Systems, Inc. (US) - Schiller AG (Switzerland) - seca GmbH & Co. KG. (Germany) - Spacelabs Healthcare, Inc. (US) - Tanita Corporation (Japan) - Welch Allyn, Inc. (US) 7. GLOBAL MARKET PERSPECTIVE For more information visit http://www.researchandmarkets.com/research/kl...ic_testing
CFN: 59.91 (-0.06), MGCD: 6.50 (-0.20), MR: 27.94 (+0.07), HOLX: 34.14 (-0.81)
Infusion Pumps Market 2015-2025 - 300 infusion pumps that are currently being manufactured and commercialised by more than 60 companies worldwide
M2 - Thu Dec 03, 7:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/h9gtdp/infusion_pumps) has announced the addition of the "Infusion Pumps Market, 2015-2025" report to their offering. The Infusion Pumps Market, 2015-2025 report provides a comprehensive study of the current state of infusion pumps market and the likely future evolution of these devices over the next decade. The study covers various types of infusion pumps that are used across several application areas. The current generation of these devices, being reliable and easy to use, have found wide acceptance in both homecare and hospital market. Infusion pumps are a class of drug delivery devices that have found wide adoption across different application areas. Their popularity can be attributed to their reliable, user friendly features and ergonomic design. The market has a wide array of different types of infusion pumps (volumetric, syringe, implantable, elastomeric, ambulatory and others); combined, they offer a large range of infusion volume, flow rate, occlusion alarm pressure range and many other technical parameters that can be adjusted according to the patient's requirements and care areas.These pumps have strengthened their position in a variety of application areas including oncology, diabetes, pain management, enteral feeding and general infusion. Several established firms as well as emerging players are currently competing in this market. Companies have regularly come up with technological advancements aimed at increasing the reliability and safety of these pumps. Examples of technological / design innovations include introduction of intuitive coloured touch screen, drug libraries, user friendly interface, compact design, improved accuracy, automated power saving mode and air-in-line detection.The introduction of smart infusion pumps has been an important step in the growth of this market. Despite the fact that the current market is significantly mature, a number of technological advancements from established and new players have sustained the growth momentum.Companies are continuously on the lookout for new avenues of growth in terms of novel features; this is expected to result in an even wider adoption going forward. Report Highlights: - During the course of our study, we identified over 300 infusion pumps that are currently being manufactured and commercialised by more than 60 companies worldwide. - The fragmented market is well distributed across different regions. Established companies such as (in alphabetical order) Baxter, B. Braun, Cane Medical Technology, Daiwha, Fresenius Kabi, GF Foures, Hospira, Medtronic, Micrel Medical Devices, Mindray, Smiths Medical, which have a wide portfolio of infusion pump devices are staring at growing competition from several mid-sized players and upcoming start-ups. - Examples of start-ups / smaller firms (in alphabetical order) include CareFusion, Cellnovo, CME Medical, Expanding Industry Limited, Flowonix, Summit Medical Products, Zyno Medical (complete list in Chapter 4). As has been observed in the case of other medical devices, the newer / smaller players will continue to foster more innovation and drive the market further. - The increasing number of partnerships among several players clearly indicates the growth and changes being witnessed in the market. These collaborations range from product / software development, distribution arrangements and acquisitions. - We expect the overall market to grow at an annualised growth rate of 3.8% during the period 2015-2025. Specific pockets of growth will come from wider adoption for oncology, diabetes and pain management applications. In terms of product types, ambulatory infusion pumps are likely to witness a relatively higher growth. - Advancements in device safety, software developments, accuracy rates and incorporation of additional user friendly features are likely to act as key enablers for future growth. The homecare market, specifically, is expected to grow its share in the future owing to the fact that it is cost effective and reduces the hospital expenses incurred by patients for various treatments. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction 4. Market Overview 5. Infusion Pumps For General Infusion 6. Infusion Pumps For Pain Management 7. Infusion Pumps For Oncology 8. Infusion Pumps For Insulin Administration 9. Case Studies 10. Market Forecast 11. Company Profiles 12. Conclusion 13. Appendix 1: Tabulated Data 14. Appendix 2: List Of Companies And Oragnisations Companies Mentioned - 3AF Group - AAMI Foundation - Abbott - Advanced Infusion - AKAS Medical - ALCOR Scientific - American Association of Critical-Care Nurses (AACN) - American Society of Regional Anaesthesia and Acute Pain Medicine (ASRA) - Amerinet - Angel Electronics - AngioDynamics - Animas - Arcomed - ASCOR - Asklepios Hospital Group - Atom Medical - B. Braun - Baxter - Becton Dickinson - Beijing KellyMed - Bigfoot Biomedical - Blue Box Medical - Cane Medical - CareFusion - Cellnovo - Centers for Disease Control and Prevention - Cerner - Changsha Jianyuan - CME Medical - CODAN ARGUS - Codman (J&J) - Committee for Medical Products for Human Use - CONNECT - Contec Medical - Covidien For more information visit http://www.researchandmarkets.com/research/h9...sion_pumps
MDT: 85.70 (-0.08), CFN: 59.91 (-0.06), MCRL: 13.86 (-0.09), CERN: 55.61 (-1.35)
CareFusion Receives Zenith Award For Respiratory Product Excellence
PR Newswire - Sat Nov 07, 10:40AM CST
CareFusion, a BD company (NYSE:BDX), was presented today with the Zenith Award for the second year in a row from the American Association for Respiratory Care (AARC) at the 61st International Respiratory Congress and Exhibition being held today through Nov. 10 in Tampa, Fla.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06)
CareFusion Highlights New Respiratory Solutions at AARC 2015 Congress
PR Newswire - Fri Nov 06, 6:16AM CST
CareFusion, a BD company (NYSE:BDX), will be displaying new respiratory solutions that are designed to put patients first, whether ventilated or breathing on their own, at the American Association for Respiratory Care (AARC) Congress being held Nov. 7-10 in Tampa, Fla.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06)
CareFusion AirLife Signs New Distribution Agreement with ResMed
PR Newswire - Thu Nov 05, 5:59AM CST
CareFusion, a BD company (NYSE:BDX), today announced its AirLife business line has signed an exclusive agreement with ResMed (NYSE:RMD) to distribute innovative nasal high flow interface products from the company.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06), RMD: 59.80 (-0.70)
CareFusion Signs Exclusive Distribution Agreement With AAM Healthcare For Video Laryngoscope
PR Newswire - Mon Oct 26, 7:30AM CDT
CareFusion, a BD company (NYSE: BDX), today announced its Vital Signs anesthesia delivery and patient monitoring business has entered into an exclusive agreement with AAM Healthcare to distribute its APA(TM) video laryngoscope in the U.S. and 12 other countries.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06)
Stryker announces completion of the acquisition of vertebral compression fracture portfolio from BD
Globe Newswire - Thu Apr 21, 7:00AM CDT
Kalamazoo, Michigan - April 21, 2016 - Stryker Corporation (NYSE: SYK) announced today it has completed the acquisition of the CareFusion vertebral compression fracture (VCF) portfolio of products from BD (Becton, Dickinson and Company) in an all cash transaction. The portfolio is comprised of minimally-invasive systems used in vertebroplasty and vertebral augmentation procedures. BD acquired these assets as a part of CareFusion's portfolio in March of 2015.
CFN: 59.91 (-0.06), SYK: 114.56 (-0.77)
Global Infusion Pumps Market Worth USD 4922 Million by 2025 - Analysis, Technologies & Forecasts Report 2015-2025 - Key Vendors: Baxter, Braun, CareFusion - Research and Markets
BusinessWire - Mon Apr 11, 4:03AM CDT
Research and Markets has announced the addition of the "Infusion Pumps Market: Global Industry Analysis and Opportunity Assessment, 2015-2025" report to their offering.
CFN: 59.91 (-0.06)
United States Breast Biopsy and Imaging Market 2016
M2 - Fri Jan 15, 3:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/lxb4c5/us_market_for) has announced the addition of the "US Market for Breast Biopsy and Imaging - 2016" report to their offering. In recent years, improvements in breast imaging technology, especially in breast ultrasound technology, have enhanced a physician's ability to identify more and smaller microcalcifications in the breast. The breast imaging market includes analog, computed and digital radiography mammography, digital breast tomosynthesis, manual and automated breast ultrasound, gamma imaging, positron emission mammography and breast MRI coils. Improvements in breast imaging techniques are expected to help increase the number of breast biopsy procedures and therefore, sales of breast biopsy devices, as more breast lesions are detected. New mammography technologies and the growth of complementary modalities have grown the breast imaging market. Key Topics Covered: 1 Overview 1.1 Breast Biopsy Device Market 1.2 Breast Imaging Equipment Market 2 Research Methodology 3 Breast Biopsy Device Market 3.1 Introduction 3.2 Market Overview 3.3 Market Analysis And Forecast 3.3.1 Total Breast Biopsy Device Market 3.3.2 Core Needle Device Market 3.3.3 Total Vacuum-Assisted Breast Biopsy Device Market 3.3.3.1 Vacuum-Assisted Breast Biopsy Device Market By Imaging Modality 3.3.3.1.1 Ultrasound Guided Vabb Market 3.3.3.1.2 Stereotactic X-Ray Guided Vabb Market 3.3.3.1.3 Mri Guided Vabb Market 3.3.3.1.4 Molecular Imaging Guided Vabb Market 3.4 Market Drivers And Limiters 3.4.1 Market Drivers 3.4.2 Market Limiters 3.5 Competitive Analysis 4 Breast Imaging Equipment Market 4.1 Introduction 4.1.1 Mammography 4.1.1.1 Analog Mammography 4.1.1.2 Computed Radiography (Cr) 4.1.1.3 Digital Radiography (Dr) 4.1.1.4 Digital Breast Tomosynthesis (Dbt) 4.1.2 Ultrasound Imaging 4.1.2.1 Manual Breast Ultrasound 4.1.2.2 Automated Breast Ultrasound System (Abus) 4.1.3 Breast Magnetic Resonance Imaging 4.1.4 Molecular Breast Imaging (Mbi) 4.1.4.1 Gamma Imaging 4.1.4.2 Positron Emission Mammography (Pem) 4.2 Market Overview 4.3 Market Analysis And Forecast 4.3.1 Total Mammography Market 4.3.1.1 Analog Mammography Market 4.3.1.2 Computed Radiography Mammography Market 4.3.1.3 Digital Radiography Mammography Market 4.3.1.4 Digital Breast Tomosynthesis Market 4.3.2 Molecular Breast Imaging Market 4.3.2.3 Positron Emission Mammography Market 4.3.2.2 Gamma Imaging Market 4.3.3 Total Breast Ultrasound Market 4.3.3.1 Manual Breast Ultrasound Market 4.3.3.2 Automated Breast Ultrasound System Market 4.3.4 Mri Coil Market 4.4 Drivers And Limiters 4.5 Competitive Analysis Companies Mentioned - Hologic - Mammotome (Devicor) - C. R. Bard - CareFusion - Intact Medical - Scion Medical Technologies - GE Healthcare - Philips Medical Systems - Siemens Healthcare - Fujifilm - Toshiba - SuperSonic Imagine - SonoCin? - CMR-Naviscan - Hitachi - Gamma Medica Inc. - Dilon Technologies - Machnet B.V. - Planmed OY For more information visit http://www.researchandmarkets.com/research/lx...market_for
CFN: 59.91 (-0.06), HOLX: 34.14 (-0.81)
US Female & Neonatal Diagnostic Device Market Report - Analysis, Technologies & Forecasts 2016
M2 - Mon Jan 11, 6:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/cnfsfw/us_female_and) has announced the addition of the "US Female and Neonatal Diagnostic Device Market Report Suite - 2016" report to their offering. This report includes analysis and forecasting for the markets for bone densitometry (central and peripheral), breast biopsy devices (spring-loaded core needles, VABB devices, as well as breakdowns for stereotactic X-ray, ultrasound and MRI guidance), breast imaging (mammography, breast ultrasound, breast MRI coils, gamma imaging and positron emission mammography), OB/GYN ultrasound imaging, fetal and neonatal monitoring (hospital, alternate and home-use), as well as incubators and warmers. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, fetal and neonatal monitoring, infant warmers and incubators. The majority of these market segments will see stable growth throughout the forecast period of this report. In 2015, the largest segment of this market was represented by breast imaging. Companies Mentioned: - Hologic - GE Healthcare - Philips Healthcare - Siemens Healthcare - Mammotome (Devicor) - C.R. Bard - Samsung Medison - Dr?ger Medical - Norland, at Swissray - Laborie - AGFA Healthcare - Assured Imaging Mobile Mammography - Atmos Medical BeamMed - Biosound Esaote - BK Medical - CareFusion - Carestream Health - CAS Medical - CMR-Naviscan - Dilon Technologies - Dr?ger Medical - Fischer-Giotto - Fujifilm Medical - Fujifilm Sonosite - Fukuda Denshi - Gamma Medica Inc. - Hitachi Aloka Medical America Inc. - Huntleigh Healthcare - Intact Medical - International Biomedical - Konica Minolta - Laborie - Loan Oak Medical Technologies - Machnet - Mindray - Natus Medical - Nihon Kohden - Osteometer Meditech - Planmed OY - Samsung Medison - Scion Medical Technologies - SonoCine - Spacelabs Healthcare - SuperSonic Imagine - Toshiba America Medical Systems - Zonare Medical Systems Report Structure: 1. U.S. FEMALE AND NEONATAL DIAGNOSTIC DEVICE MARKET 2. RESEARCH METHODOLOGY 3. U.S. FEMALE AND NEONATAL DIAGNOSTIC DEVICE MARKET OVERVIEW 4. PROCEDURE NUMBERS 5. BONE DENSITOMETRY MARKET 6. BREAST BIOPSY DEVICE MARKET 7. BREAST IMAGING EQUIPMENT MARKET 8. OBSTETRICS AND GYNECOLOGY ULTRASOUND EQUIPMENT MARKET 9. FETAL AND NEONATAL MONITORING DEVICE MARKET 10. INFANT WARMER AND INCUBATOR MARKET 11. GYNECOLOGICAL CHAIR MARKET 12. ABBREVIATIONS 13. PROCEDURAL CODES For more information visit http://www.researchandmarkets.com/research/cn...female_and
BABY: 36.39 (-0.32), CFN: 59.91 (-0.06), MDSY: 1.50 (-0.04), HOLX: 34.14 (-0.81)
US Female and Neonatal Devices Procedure Numbers Report - Analysis, Technologies & Forecasts 2016
M2 - Mon Jan 11, 6:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/kg78mz/us_procedure) has announced the addition of the "US Procedure Numbers for Female and Neonatal Devices Featuring DXA, Breast Biopsy, Breast Imaging, and OB/GYN Ultrasound Procedures - 2016" report to their offering. This report includes analysis and forecasting for the markets for bone densitometry (central and peripheral), breast biopsy devices (spring-loaded core needles, VABB devices, as well as breakdowns for stereotactic X-ray, ultrasound and MRI guidance), breast imaging (mammography, breast ultrasound, breast MRI coils, gamma imaging and positron emission mammography), OB/GYN ultrasound imaging, fetal and neonatal monitoring (hospital, alternate and home-use), as well as incubators and warmers. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, fetal and neonatal monitoring, infant warmers and incubators. The majority of these market segments will see stable growth throughout the forecast period of this report. In 2015, the largest segment of this market was represented by breast imaging. This is primarily due to the large number of screening procedures performed with these devices, which add to the demand of the devices as well as the introduction of new technologies such as digital breast tomosynthesis (DBT) and automated breast ultrasound (ABUS). Moreover, the ASP of these devices is high in comparison to the devices from other markets discussed in this report. Companies Mentioned: - Hologic - GE Healthcare - Philips Healthcare - Siemens Healthcare - Mammotome (Devicor) - C.R. Bard - Samsung Medison - Dr?ger Medical - Norland, at Swissray - Laborie - AGFA Healthcare - Assured Imaging Mobile Mammography - Atmos Medical BeamMed - Biosound Esaote - BK Medical - CareFusion - Carestream Health - CAS Medical - CMR-Naviscan - Dilon Technologies - Dr?ger Medical - Fischer-Giotto - Fujifilm Medical - Fujifilm Sonosite - Fukuda Denshi - Gamma Medica Inc. - Hitachi Aloka Medical America Inc. - Huntleigh Healthcare - Intact Medical - International Biomedical - Konica Minolta - Laborie - Loan Oak Medical Technologies - Machnet - Mindray - Natus Medical - Nihon Kohden - Osteometer Meditech - Planmed OY - Samsung Medison - Scion Medical Technologies - SonoCine - Spacelabs Healthcare - SuperSonic Imagine - Toshiba America Medical Systems - Zonare Medical Systems Report Structure: 1.1 PROCEDURE NUMBERS 2. RESEARCH METHODOLOGY 3. PROCEDURE NUMBERS 4. ABBREVIATIONS 5. PROCEDURAL CODES For more information visit http://www.researchandmarkets.com/research/kg..._procedure
BABY: 36.39 (-0.32), CFN: 59.91 (-0.06), MDSY: 1.50 (-0.04), HOLX: 34.14 (-0.81)
mHealth and Home Monitoring Market Report: 2015 Edition - How Should the Mobile Industry Address the Vast Business Opportunity in Wireless Healthcare Monitoring
M2 - Wed Dec 16, 3:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/jnfv9z/mhealth_and_home) has announced the addition of the "mHealth and Home Monitoring - 7th Edition " report to their offering. How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? The number of home monitoring devices on the global market with integrated cellular connectivity was 3.0 million at the end of 2015 and is forecasted to grow at a CAGR of 45.4 percent in the next five years to reach 19.2 million in 2020. Learn more about how wireless technology can become seamlessly integrated with medical devices in this 250 page in-depth report now in its seventh edition. mHealth and Home Monitoring is the seventh consecutive report that gives first-hand insights into the adoption of wireless solutions for health monitoring. This strategic research report provides you with 250 pages of unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions. This report will allow you to: - Profit from 40 new executive interviews with market leading companies. - Study the strategies of 108 key players in the mHealth ecosystem. - Learn about key home health monitoring devices and services. - Understand the dynamics of the health monitoring market in Europe and North America. - Comprehend how wireless technology can become seamlessly integrated with medical devices. - Evaluate the business opportunities in the emerging mHealth segment. - Predict future market and technology developments. This report answers the following questions: - Which medical conditions offer the best potential for wireless health monitoring solutions? - Who are the leading providers of connected medical devices? - What are the mHealth strategies of medical device vendors and pharmaceutical companies? - Which are the general technology trends for home health monitoring equipment? - What initiatives have been taken by the leading players in the telecom and IT industries? - How can connectivity redefine the use cases of medical devices and the value propositions to patients and other stakeholders? - What are the market shares of the top 5 integrated telehealth solution vendors? - Why are smartphone applications so significant for the mHealth market? - How can healthcare providers and payers benefit from mHealth solutions? Key Topics Covered: Executive summary 1 The challenge from welfare diseases 2 mHealth platforms 3 Physiological monitoring solution providers 4 Medication and integrated monitoring solution providers 5 Market analysis and forecasts Companies Mentioned - 35 of the 100 Companies Featured - A&D Medical - AT&T - Abbott - Aerocrine - Aerotel Medical Systems - Alere - AliveCor - Apple HealthKit - AstraZeneca - AuthentiDate - Bayer Healthcare - BePatient - BioTelemetry - Biotronik - BodyTel - Bosch Healthcare - Boston Scientific - Cadwell Laboratories - CardioComm Solutions - Cardiocom - Care Innovations - CareFusion - ChoiceMMed - Clement Clarke International - CoaguSense - Compliance Meds Technologies - Compumedics - DayaMed - Dexcom - Domicalis - eDevice - Ericsson - Evondos - Exco InTouch - Fisher & Paykel Healthcare For more information visit http://www.researchandmarkets.com/research/jn...h_and_home
BSX: 23.02 (-0.30), CFN: 59.91 (-0.06), MDSY: 1.50 (-0.04)
CareFusion Receives Two 510(K) Clearances for Spine Products
M2 - Fri Dec 11, 8:19AM CST
CareFusion, a BD company (NYSE:BDX), today announced the U.S. Food and Drug Administration (FDA) has cleared two 510(k)s for its spine augmentation devices.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06)
Global Respiratory Disease Testing Market 2015-2019 - Key Vendors are Alere, CareFusion, Nihon Kohden, Philips Healthcare & Smiths Medical
PR Newswire Europe - Tue Dec 08, 4:01AM CST
DUBLIN, December 8, 2015 /PRNewswire/ --
CFN: 59.91 (-0.06)
BD Introduces Simplified Comprehensive IV Management
M2 - Mon Dec 07, 10:15AM CST
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a simplified way for hospitals to manage intravenous (IV) medication to help improve safety and reduce waste.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06)
Research and Markets: Metabolic Testing Solutions - Global Strategic Business Report - Key Players are AEI Technologies, Bodystat, CareFusion, CORTEX Biophysik GmbH & COSMED
BusinessWire - Fri Dec 04, 7:21AM CST
Research and Markets (http://www.researchandmarkets.com/research/xwsjvw/metabolic_testing) has announced the addition of the "Metabolic Testing Solutions - Global Strategic Business Report" report to their offering.
CFN: 59.91 (-0.06)
Global Respiratory Disease Testing Market 2015-2019
M2 - Fri Dec 04, 5:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/fb79kb/global) has announced the addition of the "Global Respiratory Disease Testing Market 2015-2019" report to their offering. The report forecasts the global respiratory disease testing market to grow at a CAGR of 7.46% over the period 2014-2019 The report covers the current scenario and the growth prospects of the global respiratory disease testing market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of testing devices used to diagnose acute and chronic respiratory diseases. The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the landscape of the global respiratory disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Market landscape PART 06: Market segmentation by test PART 07: Market segmentation by mechanical and screening test PART 08: Market segmentation by IVD test PART 09: Geographical segmentation PART 10: Market drivers PART 11: Impact of drivers PART 12: Market challenges PART 13: Impact of drivers and challenges PART 14: Market trends PART 15: Vendor landscape PART 16: Key vendor analysis - Alere - CareFusion - COSMED - Nihon Kohden - Philips Healthcare - Smiths Medical - Diamedix - Affymetrix - Seegene - Cepheid - NDD Medical Technologies - COSMED - Abbott - F. Hoffmann-La Roche - Siemens Healthcare - Instrumentation Laboratories - Covidien - SDI Diagnostics - Futuremed America. For more information visit http://www.researchandmarkets.com/research/fb79kb/global
CFN: 59.91 (-0.06), CPHD: 28.27 (-0.60)
Metabolic Testing Solutions - Global Strategic Business Report - Key Players are AEI Technologies, Bodystat, CareFusion, CORTEX Biophysik GmbH & COSMED
M2 - Fri Dec 04, 4:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/klmhsw/metabolic_testing) has announced the addition of the "Metabolic Testing Solutions - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Metabolic Testing Solutions in US$ Thousand by the following Product Segments: ECGs/EKGs, Metabolic Carts, CPET Systems, and Others. The market is also analyzed by the following Technologies: VO2 Max Analysis, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 91 companies including many key and niche players such as - - AEI Technologies, Inc. - Bodystat Limited - CareFusion Corporation - CORTEX Biophysik GmbH - COSMED Key Topics Covered: 1. OUTLOOK 2. INDUSTRY OVERVIEW 3. PRODUCT OVERVIEW 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS - AEI Technologies, Inc. (US) - Bodystat Limited (UK) - CareFusion Corporation (US) - CORTEX Biophysik GmbH (Germany) - COSMED (Italy) - GE Healthcare (UK) - Geratherm Medical AG (Germany) - Hologic, Inc. (US) - InBody Co., Ltd. (South Korea) - Iworx Systems, Inc. (US) - Jawon Medical Co. Ltd. (South Korea) - KORR Medical Technologies, Inc. (US) - Laica SpA (Italy) - MGC Diagnostics Corporation (US) - Microlife Medical Home Solutions, Inc. (US) - Mindray Medical International Limited (China) - Mortara Instrument, Inc. (US) - Nihon Kohden Corporation (Japan) - Noraxon U.S.A., Inc. (US) - Omron Healthcare, Inc. (US) - Parvo Medics (US) - Philips Healthcare (Netherlands) - RJL Systems, Inc. (US) - Schiller AG (Switzerland) - seca GmbH & Co. KG. (Germany) - Spacelabs Healthcare, Inc. (US) - Tanita Corporation (Japan) - Welch Allyn, Inc. (US) 7. GLOBAL MARKET PERSPECTIVE For more information visit http://www.researchandmarkets.com/research/kl...ic_testing
CFN: 59.91 (-0.06), MGCD: 6.50 (-0.20), MR: 27.94 (+0.07), HOLX: 34.14 (-0.81)
Infusion Pumps Market 2015-2025 - 300 infusion pumps that are currently being manufactured and commercialised by more than 60 companies worldwide
M2 - Thu Dec 03, 7:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/h9gtdp/infusion_pumps) has announced the addition of the "Infusion Pumps Market, 2015-2025" report to their offering. The Infusion Pumps Market, 2015-2025 report provides a comprehensive study of the current state of infusion pumps market and the likely future evolution of these devices over the next decade. The study covers various types of infusion pumps that are used across several application areas. The current generation of these devices, being reliable and easy to use, have found wide acceptance in both homecare and hospital market. Infusion pumps are a class of drug delivery devices that have found wide adoption across different application areas. Their popularity can be attributed to their reliable, user friendly features and ergonomic design. The market has a wide array of different types of infusion pumps (volumetric, syringe, implantable, elastomeric, ambulatory and others); combined, they offer a large range of infusion volume, flow rate, occlusion alarm pressure range and many other technical parameters that can be adjusted according to the patient's requirements and care areas.These pumps have strengthened their position in a variety of application areas including oncology, diabetes, pain management, enteral feeding and general infusion. Several established firms as well as emerging players are currently competing in this market. Companies have regularly come up with technological advancements aimed at increasing the reliability and safety of these pumps. Examples of technological / design innovations include introduction of intuitive coloured touch screen, drug libraries, user friendly interface, compact design, improved accuracy, automated power saving mode and air-in-line detection.The introduction of smart infusion pumps has been an important step in the growth of this market. Despite the fact that the current market is significantly mature, a number of technological advancements from established and new players have sustained the growth momentum.Companies are continuously on the lookout for new avenues of growth in terms of novel features; this is expected to result in an even wider adoption going forward. Report Highlights: - During the course of our study, we identified over 300 infusion pumps that are currently being manufactured and commercialised by more than 60 companies worldwide. - The fragmented market is well distributed across different regions. Established companies such as (in alphabetical order) Baxter, B. Braun, Cane Medical Technology, Daiwha, Fresenius Kabi, GF Foures, Hospira, Medtronic, Micrel Medical Devices, Mindray, Smiths Medical, which have a wide portfolio of infusion pump devices are staring at growing competition from several mid-sized players and upcoming start-ups. - Examples of start-ups / smaller firms (in alphabetical order) include CareFusion, Cellnovo, CME Medical, Expanding Industry Limited, Flowonix, Summit Medical Products, Zyno Medical (complete list in Chapter 4). As has been observed in the case of other medical devices, the newer / smaller players will continue to foster more innovation and drive the market further. - The increasing number of partnerships among several players clearly indicates the growth and changes being witnessed in the market. These collaborations range from product / software development, distribution arrangements and acquisitions. - We expect the overall market to grow at an annualised growth rate of 3.8% during the period 2015-2025. Specific pockets of growth will come from wider adoption for oncology, diabetes and pain management applications. In terms of product types, ambulatory infusion pumps are likely to witness a relatively higher growth. - Advancements in device safety, software developments, accuracy rates and incorporation of additional user friendly features are likely to act as key enablers for future growth. The homecare market, specifically, is expected to grow its share in the future owing to the fact that it is cost effective and reduces the hospital expenses incurred by patients for various treatments. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction 4. Market Overview 5. Infusion Pumps For General Infusion 6. Infusion Pumps For Pain Management 7. Infusion Pumps For Oncology 8. Infusion Pumps For Insulin Administration 9. Case Studies 10. Market Forecast 11. Company Profiles 12. Conclusion 13. Appendix 1: Tabulated Data 14. Appendix 2: List Of Companies And Oragnisations Companies Mentioned - 3AF Group - AAMI Foundation - Abbott - Advanced Infusion - AKAS Medical - ALCOR Scientific - American Association of Critical-Care Nurses (AACN) - American Society of Regional Anaesthesia and Acute Pain Medicine (ASRA) - Amerinet - Angel Electronics - AngioDynamics - Animas - Arcomed - ASCOR - Asklepios Hospital Group - Atom Medical - B. Braun - Baxter - Becton Dickinson - Beijing KellyMed - Bigfoot Biomedical - Blue Box Medical - Cane Medical - CareFusion - Cellnovo - Centers for Disease Control and Prevention - Cerner - Changsha Jianyuan - CME Medical - CODAN ARGUS - Codman (J&J) - Committee for Medical Products for Human Use - CONNECT - Contec Medical - Covidien For more information visit http://www.researchandmarkets.com/research/h9...sion_pumps
MDT: 85.70 (-0.08), CFN: 59.91 (-0.06), MCRL: 13.86 (-0.09), CERN: 55.61 (-1.35)
CareFusion Receives Zenith Award For Respiratory Product Excellence
PR Newswire - Sat Nov 07, 10:40AM CST
CareFusion, a BD company (NYSE:BDX), was presented today with the Zenith Award for the second year in a row from the American Association for Respiratory Care (AARC) at the 61st International Respiratory Congress and Exhibition being held today through Nov. 10 in Tampa, Fla.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06)
CareFusion Highlights New Respiratory Solutions at AARC 2015 Congress
PR Newswire - Fri Nov 06, 6:16AM CST
CareFusion, a BD company (NYSE:BDX), will be displaying new respiratory solutions that are designed to put patients first, whether ventilated or breathing on their own, at the American Association for Respiratory Care (AARC) Congress being held Nov. 7-10 in Tampa, Fla.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06)
CareFusion AirLife Signs New Distribution Agreement with ResMed
PR Newswire - Thu Nov 05, 5:59AM CST
CareFusion, a BD company (NYSE:BDX), today announced its AirLife business line has signed an exclusive agreement with ResMed (NYSE:RMD) to distribute innovative nasal high flow interface products from the company.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06), RMD: 59.80 (-0.70)
CareFusion Signs Exclusive Distribution Agreement With AAM Healthcare For Video Laryngoscope
PR Newswire - Mon Oct 26, 7:30AM CDT
CareFusion, a BD company (NYSE: BDX), today announced its Vital Signs anesthesia delivery and patient monitoring business has entered into an exclusive agreement with AAM Healthcare to distribute its APA(TM) video laryngoscope in the U.S. and 12 other countries.
BDX: 169.29 (-0.94), CFN: 59.91 (-0.06)
